PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES (EP3244930A1)
Summary
The European Patent Office granted patent EP3244930A1 to the University of Southern California covering pharmaceutical compositions comprising POH derivatives with anti-cancer properties. The patent names Thomas Chen, Daniel Levin, and Satish G. Pupalli as inventors. The patent is classified under A61P 35/00 (antineoplastic agents) and designates all European member states including DE, FR, GB, IT, ES, and NL.
What changed
The European Patent Office published patent application EP3244930A1 for the University of Southern California covering pharmaceutical compositions containing POH derivatives for anti-cancer applications. The patent includes claims related to heterocyclic compounds (C07D classifications) and therapeutic compositions (A61K, A61P 35/00). The designated states cover all European Patent Convention member countries.
Pharmaceutical companies and research institutions developing cancer therapeutics should review this patent for freedom-to-operate considerations and potential licensing opportunities. Patent holders should monitor maintenance fee deadlines to preserve patent rights in desired jurisdictions.
What to do next
- Monitor patent maintenance deadlines
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES
Publication EP3244930A1 Kind: A1 Apr 08, 2026
Applicants
University of Southern California
Inventors
CHEN, Thomas, LEVIN, Daniel, PUPALLI, Satish G.
IPC Classifications
A61K 31/415 20060101AFI20251120BHEP A61K 47/54 20170101ALI20251120BHEP A61K 47/55 20170101ALI20251120BHEP C07D 207/26 20060101ALI20251120BHEP A61K 31/4015 20060101ALI20251120BHEP C07D 487/04 20060101ALI20251120BHEP C07D 231/12 20060101ALI20251120BHEP A61N 5/10 20060101ALI20251120BHEP A61K 9/00 20060101ALI20251120BHEP A61K 45/06 20060101ALI20251120BHEP A61P 35/00 20060101ALI20251120BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.